Ad is loading...

REPL Replimune Group Forecast, Technical & Fundamental Analysis

a developer of oncolytic immunotherapies

Industry Biotechnology

Get AI intraday signals

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for Free)

View a ticker or compare two or three

Compare

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

REPL is expected to report earnings to rise 11.03% to -75 cents per share on February 06

Replimune Group REPL Stock Earnings Reports

Q4'24

Est.

$-0.75

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.08

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.12

The last earnings report on November 12 showed earnings per share of -68 cents, beating the estimate of -81 cents. With 938.24K shares outstanding, the current market capitalization sits at 768.33M.

A.I. Advisor

published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Unicorn Park Drive

Phone

+1 781 222-9600

Employees

284

Web

https://www.replimune.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
PGKCX	26.45	0.43	+1.65%
PGIM Jennison Technology C
GILAX	14.14	0.16	+1.14%
Lord Abbett Fundamental Equity C
REAIX	28.06	0.17	+0.61%
American Century Real Estate I
PLCGX	21.98	0.11	+0.50%
Principal LargeCap Growth I R6
DAMDX	27.32	0.11	+0.40%
Dunham Monthly Distribution A

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with ELVAF. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then ELVAF could also see price increases.

Ticker / NAME	Correlation To REPL	1D Price Change %
REPL	100%	-1.60%
ELVAF - REPL	60% Loosely correlated	N/A
MDGL - REPL	56% Loosely correlated	+3.83%
AXON - REPL	41% Loosely correlated	+3.52%
ORMP - REPL	39% Loosely correlated	+2.21%
GBIO - REPL	35% Loosely correlated	-2.22%
More